INVIR IO
LIVE

Serial Number

79226928

Owner

TRANSGENE SA

Attorney

Pina M. Campagna

Filing Date

Nov 16, 2017

Add to watchlist:

No watchlists yet
View on USPTO

INVIR IO Trademark

Serial Number: 79226928 • Registration: 6937963

INVIR IO is a trademark filed by TRANSGENE SA on November 16, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

TRANSGENE SA (4 trademarks)

Parc d'Innovation,
ILLKIRCH GRAFFENSTADEN F-67400 , FR

Entity Type: 99

Trademark Details

Filing Date

November 16, 2017

Registration Date

January 3, 2023

Published for Opposition

October 18, 2022

Goods & Services

Therapeutic vaccines in oncology; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, for use in oncology; Human therapeutic vaccine preparations for use in oncology; immunotherapy products in oncology for human use being anti-cancer preparations

Design and development of therapeutic vaccines and immunotherapy products in oncology

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 9, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 15, 2023 FICS
FINAL DISPOSITION PROCESSED
Apr 14, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 3, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 3, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 3, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 18, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 18, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Oct 17, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 28, 2022 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 28, 2022 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 28, 2022 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 12, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 24, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 24, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 7, 2022 CNRT
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 22, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 21, 2021 RCSC
NEW REPRESENTATIVE AT IB RECEIVED
Feb 27, 2021 NREP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 19, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 19, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 19, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 19, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 19, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 19, 2021 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 19, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 13, 2020 RCSC
ASSIGNED TO LIE
May 11, 2020 ALIE
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 25, 2019 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 2, 2019 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 17, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 17, 2019 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 24, 2019 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 23, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 23, 2018 GNSL
SUSPENSION LETTER WRITTEN
Oct 23, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 12, 2018 TROA
REFUSAL PROCESSED BY IB
Mar 30, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 12, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 12, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 6, 2018 RFCR
NON-FINAL ACTION WRITTEN
Mar 5, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 2, 2018 MAFR
ASSIGNED TO EXAMINER
Feb 28, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 15, 2018 REPR